Publication | Closed Access

Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial

ThrombosisCardiovascular DiseaseTra 2°P-timi 50MedicineSecondary PreventionPharmacotherapyPlatelet AntagonistPrevious Myocardial InfarctionAnticoagulantCardiologyCoronary Artery DiseaseAnesthesiologyMyocardial Infarction